U.S. Medical Waste Container Market Size, Share, Trends, Industry Analysis Report By Product (Chemotherapy Containers, Biohazardous Waste Containers, Sharps Waste Containers), By Waste Type, By End Use

Description

List of Tables

The U.S. medical waste container market size is expected to reach USD 845.26 million by 2034, according to a new study by Polaris Market Research. The report "U.S. Medical Waste Container Market Share, Size, Trends, Industry Analysis Report By Product (Chemotherapy Containers, Biohazardous Waste Containers, Sharps Waste Containers), By Waste Type, By End Use; Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

A medical waste container is a specialized box designed to safely collect, store, and dispose of hazardous biomedical waste generated in healthcare facilities, laboratories, and research centers. These containers are made from durable medical polymer or metal and are often color-coded to ensure proper segregation. They may include features such as lids, labels, and puncture resistance for sharps disposal. Medical waste containers help prevent contamination, infection, and environmental harm by ensuring safe handling and compliance with regulatory standards.

In the U.S., medical waste containers must comply with strict federal and state regulations, including OSHA, EPA, and DOT guidelines. They are categorized based on waste types such as sharps, pathological, or pharmaceutical waste and must meet specific labeling and durability standards. Many U.S. facilities use reusable or disposable containers with biohazard symbols for easy identification. Proper disposal often involves autoclaving, incineration, or licensed medical waste haulers. The U.S. emphasizes segregation at the source to reduce cross-contamination and ensure safe processing, aligning with public health and environmental safety goals,

U.S. Medical Waste Container Market Report Highlights

In terms of product, the chemotherapy containers segment accounted for 36.22% of revenue share in 2024 due to the increasing incidence of cancer and the corresponding rise in chemotherapy treatments across hospitals and oncology centers.

The resource conservation and recovery act (RCRA) containers segment is projected to register a CAGR of 7.17% from 2025 to 2034, owing to a rise in hazardous waste generated from laboratories, research centers, and pharmaceutical manufacturing units.

Based on waste type, the general waste segment held 37.22% of the U.S. medical waste container market share in 2024 due to the high volume of non-hazardous waste generated across hospitals, clinics, and outpatient facilities.

The sharps waste segment is expected to register a CAGR of 9.51% from 2025 to 2034, owing to the rising use of needles, syringes, scalpels, and other sharp instruments in both inpatient and outpatient care.

In terms of end use, the hospitals & private clinics segment dominated the U.S. medical waste container market share in 2024 by holding 39.22% revenue share. This is attributed to their substantial contribution to overall medical waste generation.

The pharmaceutical and biotechnology companies & CROs segment is estimated to register a CAGR of 7.48% from 2025 to 2034 due to a surge in drug development activities, clinical trials, and biomanufacturing processes.

A few key market players include Becton Dickinson; Bemis Manufacturing Company; Bondtech Corporation; Cardinal Health; Daniels Health; EnviroTain, LLC.; Henry Schein, Inc.; Mauser Packaging Solutions; Stericycle, Inc.; Terra Universal; and Thermo Fisher Scientific Inc.

Polaris Market Research has segmented the U.S. medical waste container market report on the basis of product, waste type, and end use:

By Product Type Outlook (Revenue, USD Million, 2021-2034)

Chemotherapy Containers

Biohazardous Waste Containers

Sharps Waste Containers

Resource Conservation and Recovery Act (RCRA) Containers

Others

By Waste Type Outlook (Revenue, USD Million, 2021-2034)

General Waste

Infectious Waste

Hazardous Waste

Radioactive Waste

Sharps Waste

By End Use Outlook (Revenue, USD Million, 2021-2034)

Hospitals & Private Clinics

Diagnostic Laboratories

Pharmaceutical and Biotechnology Companies & CROs

Academic Research Institutes

Others

Product Code: PM6252

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Source
- 3.2.1. Primary Source
- 3.2.2. Secondary Source

4. U.S. Medical Waste Container Market Insights

4.1. Medical Waste Container Market - Market Snapshot
4.2. Medical Waste Container Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Growing Geriatric Population
  - 4.2.1.2. Increasing Minimally Invasive Surgeries
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. Lack of awareness regarding medical waste
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Medical Waste Container Market Trends
4.6. Value Chain Analysis

5. U.S. Medical Waste Container Market, by Product

5.1. Key Findings
5.2. Introduction
- 5.2.1. U.S. Medical Waste Container Market, by Product, 2020-2034 (USD Million)
5.3. Chemotherapy Containers
- 5.3.1. U.S. Medical Waste Container Market, by Chemotherapy Containers, by Region, 2020-2034 (USD Million)
5.4. Biohazardous Waste Containers
- 5.4.1. U.S. Medical Waste Container Market, by Biohazardous Waste Containers, by Region, 2020-2034 (USD Million)
5.5. Sharps Waste Containers
- 5.5.1. U.S. Medical Waste Container Market, by Sharps Waste Containers, by Region, 2020-2034 (USD Million)
5.6. Resource Conservation and Recovery Act (RCRA) Containers
- 5.6.1. U.S. Medical Waste Container Market, by Resource Conservation and Recovery Act (RCRA) Containers, by Region, 2020-2034 (USD Million)
5.7. Others
- 5.7.1. U.S. Medical Waste Container Market, by Others, by Region, 2020-2034 (USD Million)

6. U.S. Medical Waste Container Market, by Waste Type

6.1. Key Findings
6.2. Introduction
- 6.2.1. U.S. Medical Waste Container Market, by Waste Type, 2020-2034 (USD Million)
6.3. General Waste
- 6.3.1. U.S. Medical Waste Container Market, by General Waste, by Region, 2020-2034 (USD Million)
6.4. Infectious Waste
- 6.4.1. U.S. Medical Waste Container Market, by Infectious Waste, by Region, 2020-2034 (USD Million)
6.5. Hazardous Waste
- 6.5.1. U.S. Medical Waste Container Market, by Hazardous Waste, by Region, 2020-2034 (USD Million)
6.6. Radioactive Waste
- 6.6.1. U.S. Medical Waste Container Market, by Radioactive Waste, by Region, 2020-2034 (USD Million)
6.7. Sharps Waste
- 6.7.1. U.S. Medical Waste Container Market, by Sharps Waste, by Region, 2020-2034 (USD Million)

7. U.S. Medical Waste Container Market, by End Use

7.1. Key Findings
7.2. Introduction
- 7.2.1. U.S. Medical Waste Container Market, by End Use, 2020-2034 (USD Million)
7.3. Hospitals & Private Clinics
- 7.3.1. U.S. Medical Waste Container Market, by Hospitals & Private Clinics, by Region, 2020-2034 (USD Million)
7.4. Diagnostic Laboratories
- 7.4.1. U.S. Medical Waste Container Market, by Diagnostic Laboratories, by Region, 2020-2034 (USD Million)
7.5. Pharmaceutical and Biotechnology Companies & CROs
- 7.5.1. U.S. Medical Waste Container Market, by Pharmaceutical and Biotechnology Companies & CROs, by Region, 2020-2034 (USD Million)
7.6. Food Science
- 7.6.1. U.S. Medical Waste Container Market, by Food Science, by Region, 2020-2034 (USD Million)
7.7. Academic Research Institutes
- 7.7.1. U.S. Medical Waste Container Market, by Academic Research Institutes, by Region, 2020-2034 (USD Million)
7.8. Others
- 7.8.1. U.S. Medical Waste Container Market, by Others, by Region, 2020-2034 (USD Million)

8. Competitive Landscape

8.1. Expansion and Acquisition Analysis
- 8.1.1. Expansion
- 8.1.2. Acquisitions
8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

9.1. Becton Dickinson
- 9.1.1. Company Overview
- 9.1.2. Financial Performance
- 9.1.3. Product Benchmarking
- 9.1.4. Recent Development
9.2. Bondtech Corporation
- 9.2.1. Company Overview
- 9.2.2. Financial Performance
- 9.2.3. Product Benchmarking
- 9.2.4. Recent Development
9.3. Bemis Manufacturing Company
- 9.3.1. Company Overview
- 9.3.2. Financial Performance
- 9.3.3. Product Benchmarking
- 9.3.4. Recent Development
9.4. Cardinal Health
- 9.4.1. Company Overview
- 9.4.2. Financial Performance
- 9.4.3. Product Benchmarking
- 9.4.4. Recent Development
9.5. Daniels Health
- 9.5.1. Company Overview
- 9.5.2. Financial Performance
- 9.5.3. Product Benchmarking
- 9.5.4. Recent Development
9.6. EnviroTain, LLC.
- 9.6.1. Company Overview
- 9.6.2. Financial Performance
- 9.6.3. Product Benchmarking
- 9.6.4. Recent Development
9.7. Henry Schein, Inc.
- 9.7.1. Company Overview
- 9.7.2. Financial Performance
- 9.7.3. Product Benchmarking
- 9.7.4. Recent Development
9.8. Mauser Packaging Solutions
- 9.8.1. Company Overview
- 9.8.2. Financial Performance
- 9.8.3. Product Benchmarking
- 9.8.4. Recent Development
9.9. Stericycle, Inc.
- 9.9.1. Company Overview
- 9.9.2. Financial Performance
- 9.9.3. Product Benchmarking
- 9.9.4. Recent Development
9.10. Terra Universal
- 9.10.1. Company Overview
- 9.10.2. Financial Performance
- 9.10.3. Product Benchmarking
- 9.10.4. Recent Development
9.11. Thermo Fisher Scientific Inc.
- 9.11.1. Company Overview
- 9.11.2. Financial Performance
- 9.11.3. Product Benchmarking
- 9.11.4. Recent Development